The School of Molecular and Cellular Biology at the University of Illinois at Urbana-Champaign

mcb The School of Molecular and Cellular Biology The University of Illinois at Urbana-Champaign logo The University of Illinois at Urbana-Champaign The School of Molecular and Cellular Biology

Main Navigation

Department of Molecular and Integrative Physiology
Jongsook Kim Kemper

jongsook@illinois.edu

283 Burrill Hall
Office: ( 217) 333-6317
Lab: (217) 244-2236
Fax: (217) 333-1133

Mail to:
Department of Molecular & Integrative Physiology
524 Burrill Hall
407 S. Goodwin Ave
Urbana, IL 61801

Lab Page

Jongsook Kim Kemper

Associate Professor of Molecular and Integrative Physiology

Education

B.S., Seoul National University, Korea
Ph.D., University of Illinois at Urbana-Champaign
Postdoc., University of Illinois at Urbana-Champaign
Postdoc., Stanford University

Role of orphan nuclear receptors in cholesterol/bile acid metabolism: Applications to metabolic disorders including hypercholesterolemia, diabetes, and obesity.

I. Function of SHP in cholesterol/bile acid metabolism
The orphan nuclear receptor and transcriptional repressor, small heterodimer partner (SHP), inhibits the activities of many nuclear receptors that regulate diverse biological pathways. Our current research focuses on understanding SHP action in the regulation of key genes involved in cholesterol/bile acid metabolism. Recently we reported that SHP inhibits transcription of cholesterol 7alpha hydroxylase (CYP7A1), a key enzyme in cholesterol conversion into bile acids, by actively recruiting the chromatin modifying complexes, mSin3A/HDAC-1 and the Swi/Snf-Brm, to the promoter. Histone methyltransferase, G9a, is also recruited to the CYP7A1 promoter in a SHP-dependent manner and critically involved in SHP action. We are currently studying the functional interplay among these complexes in the inhibitory action of SHP and the roles of these complexes in bile acid metabolism. Using mouse tail vein injection of adenovirus producing flag-SHP and proteomic techniques, we are currently working on identification of SHP-interacting proteins and post-translational modification of SHP which are involved in bile acid signaling.

II. Molecular regulation of FXR activity in bile acid signaling
The overall aim of this research is to understand the function and mechanism of nuclear bile acid receptor FXR in bile acid signaling in vivo. FXR plays a central role in cholesterol/bile acid homeostasis, protecting the liver from toxic bile acids, lipid and glucose metabolism, liver regeneration, and inhibition of intestinal bacterial growth. Although such important biological functions of FXR have now been revealed, how FXR activity is regulated remains largely unknown. We are particularly interested in how FXR activity is modulated by the transcriptional cofactors, such as p300 acetylase and SIRT1 deacetylase, via acetylation of FXR itself as well as FXR target gene chromatin. Using mouse tail vein injection of adenovirus producing flag-FXR and proteomic approaches, we are also studying post-translational modification of FXR and searching for novel FXR-interacting proteins involved in bile acid-activated FXR signaling in animals in vivo.

III. Role of CAR and PXR in bile acid metabolism
The xenobiotic orphan nuclear receptors CAR and PXR play key roles in metabolism of foreign and endogenous compounds by inducing hepatic expression of cytochrome p450 enzymes. CAR and PXR have been also implicated in the suppression of hepatic bile acid biosynthesis. HNF-4 is a key transcriptional activator of hepatic genes including CYP7A1in lipid and glucose metabolism. We recently reported that PXR and CAR inhibit transcription of CYP7A1 by interfering with transactivation of the HNF-4/PGC-1alpha. CAR also inhibits CYP7A1 by inhibiting binding of HNF-4 to the DNA. We are now working on identification of functional CAR/PXR target genes involved in bile acid metabolism using chromatin immunoprecipitation/cloning techniques. We are also studying effects of different bile acids on post-translational modification of CAR/PXR in animals in vivo.

Our studies should provide critical insights into delineating roles of orphan nuclear receptors in controlling hepatic cholesterol/bile acid metabolism and should help to design novel therapeutic agents for treatment of metabolic disorders.

Representative Publications

Ponugoti, B., Fang, S., and Kemper, J.K. 2007. Functional interaction of HNF-4 and PGC-1alpha in CYP7A1regulation is inhibited by a key lipogenic activator, SREBP-1c. Molecular Endocrinology, in press.

Fang, S., Miao, J., Xiang, L., Ponugoti, B., Treuter, E., and Kemper, J.K. 2007. Coordinated recruitment of histone methyltransferase G9a and other chromatin modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. Mol. Cell. Biol., 27:1407–24. [Abstract]

Wu, S., Lee, A., Hou, S., Kemper, J.K., Erdjument-Bromage, and Chiang, C.M. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes and Development, 17:2383–96. [Abstract]

Miao, J., Fang, S., Bae, Y., and Kemper, J.K. 2006. Functional inhibitory cross-talk between CAR and HNF-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha. J. Biol Chem., 281:14537–46. [Abstract]

Bhalla, S., Ozalp, C., Fang, S., Xiang, L., and Kemper, J.K. 2004. Ligand-activated PXR interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha: functional implication in hepatic cholesterol and glucose metabolism. J. Biol. Chem., 279(43):45139–47. [Abstract]

Kemper, J.K., Kim, H., Miao, J., Bhalla, S., and Bae, Y. 2004. Role of an mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol. Cell. Biol., 24(17):7707–19. [Abstract]

Bae, Y., Kemper, J.K., and Kemper, B. 2004. Repression of CAR-mediated transactivation of CYP2B genes by the orphan nuclear receptor, small heterodimer partner (SHP). DNA and Cell Biology, 23(2):81–91. [Abstract]

Goodwin, B., Watson, M., Kim, H., Miao, J., Kemper, J.K., and Kliewer, S. 2003. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Molecular Endocrinology, 17(3):386–94. [Abstract]

Min, G., Kim, H., Bae, Y., Petz, L., and Kemper, J.K. 2002. Inhibitory cross-talk between estrogen receptor (ER) and constitutive androstane receptor (CAR): CAR inhibits ER-mediated signaling pathway by p160 coactivator competition. J. Biol. Chem., 277(37):34626–33. [Abstract]

Min, G., Kemper, J.K. and Kemper, B. 2002. Glucocorticoid receptor interacting protein-1 mediates ligand-independent nuclear translocation and activation of constitutive androstane receptor in vivo. J. Biol. Chem., 277(29):26356–63. [Abstract]

Kim, J., Min, G., and Kemper, B. 2001. Chromatin assembly enhances binding to the CYP2B1 phenobarbital-responsive unit (PBRU) of nuclear factor-1 (NF-1), which binds simultaneously with constitutive androstane receptor (CAR)/retinoid X receptor (RXR) and enhances CAR/RXR mediated activation of the PRBU. J. Biol. Chem., 276(10):7559–67. [Abstract]

Kim, J., Rivera-Rivera, I., and Kemper, B.W. 2000. Tissue-specific chromatin structure of the phenobarbital-responsive unit and proximal promoter of CYP2B1/2 and modulation by phenobarbital. Nucleic Acid Research, 28:1126–32. [Abstract]

PubMed